4//SEC Filing
Marucci Anthony S 4
Accession 0001415889-22-008769
CIK 0000744218other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:06 PM ET
Size
13.2 KB
Accession
0001415889-22-008769
Insider Transaction Report
Form 4
Marucci Anthony S
President & CEO
Transactions
- Exercise/Conversion
Incentive Stock Option
2022-08-15−75,000→ 25,000 totalExercise: $2.78Exp: 2029-06-19→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2022-08-15$2.78/sh+75,000$208,500→ 102,692 total - Exercise/Conversion
Common Stock
2022-08-15$9.02/sh+45,000$405,743→ 147,692 total - Sale
Common Stock
2022-08-15$37.66/sh−120,000$4,519,572→ 27,692 total - Exercise/Conversion
Incentive Stock Option
2022-08-15−45,000→ 26,665 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (45,000 underlying)
Footnotes (5)
- [F1]Includes 461 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.
- [F2]This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.39 to $37.95 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F4]25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
- [F5]As of June 13, 2022, the option is fully vested.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001429933
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:06 PM ET
- Size
- 13.2 KB